Recursion Pharmaceuticals RXRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q2 | 5.06 | -0.41 | -176,227 | -172 | ||
| 2025Q1 | 5.29 | 94.44 | -0.50 | -191,368 | -202 | |
| 2024Q4 | 6.76 | 102.72 | -0.57 | -183,768 | -179 | |
| 2024Q3 | 6.59 | 102.80 | -0.33 | -98,353 | -96 | |
| 2024Q2 | 7.50 | 102.53 | -0.40 | -100,543 | -98 | |
| 2024Q1 | 9.97 | 104.54 | -0.39 | -96,340 | -91 | |
| 2023Q4 | 9.86 | 101.93 | -0.42 | -98,930 | -93 | |
| 2023Q3 | 7.65 | 107.02 | -0.45 | -99,550 | -93 | |
| 2023Q2 | 7.47 | 106.50 | -0.37 | -81,715 | -77 | |
| 2023Q1 | 6.67 | 106.95 | -0.34 | -69,865 | -65 | |
| 2022Q4 | 7.71 | 106.07 | -0.30 | -60,982 | -57 | |
| 2022Q3 | 10.64 | 103.52 | -0.35 | -62,573 | -60 | |
| 2022Q2 | 8.14 | 100.96 | -0.38 | -66,191 | -66 | |
| 2022Q1 | 7.16 | 100.00 | -0.33 | -55,981 | -56 | |
| 2021Q4 | 17.13 | 100.04 | -0.39 | -64,960 | -65 | |
| 2021Q3 | 23.01 | 97.84 | -0.19 | -46,402 | -47 | |
| 2021Q2 | 36.50 | 94.30 | 0.42 | -40,929 | -43 | |
| 2021Q1 | 99.24 | -1.33 | -30,484 | -31 | ||
| 2020Q4 | -25,581 | -26 | ||||
| 2020Q3 | -22,474 | -24 |